NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Cholamandalam Investment and Finance Company Sees 25% YoY Growth in Q4 Disbursements

Prabhudas Lilladher's research report highlights the notable growth in Cholamandalam Investment and Finance Company's Q4 disbursements, which saw a year-over-year (YoY) increase of 25%. This growth was seen across various segments, contributing to a 21% YoY growth in Assets Under Management (AUM). Considering the sustained momentum, Prabhudas Lilladher forecasts AUM growth of approximately 22% in FY27 and 21% in FY28E.

The report also notes that the Net Interest Margin (NIM) is expected to remain stable at around 7%, while higher incremental yields will compensate for an increase in the Cost of Funds (CoF). Additionally, the operating expense ratio is anticipated to improve due to productivity gains. Notably, asset quality has improved quarter-over-quarter (QoQ), with credit costs standing at 1.6%. The report expects further moderation in credit costs in the first half of FY27, with Prabhudas Lilladher building in credit costs of 1.6% and 1.5% for FY27 and FY28E, respectively.

SegmentFY27EFY28E
Credit Cost1.6%1.5%

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

Performance IndicatorFY27EFY28E
AUM Growth22%21%
NIM7%7%

In light of the positive outlook on growth, credit costs, and operating expense improvement, Prabhudas Lilladher has increased its estimates. The revised forecast for FY28E Price-to-Asset Book Value (P/ABV) multiple is 3.8x, compared to the earlier estimate of 3.7x. The research firm retains its 'BUY' recommendation with a target price of INR1,950.

Investor Takeaway

Investors should consider buying Cholamandalam Investment and Finance Company with a target price of INR1,950.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.